Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Setipiprant did not significantly improve hair growth in men with hair loss.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.